Levels of serum granulocyte colony-stimulating factor in patients with infections
- PMID: 1700729
Levels of serum granulocyte colony-stimulating factor in patients with infections
Abstract
To clarify the physiologic roles of granulocyte colony-stimulating factor (G-CSF) in infectious states in vivo, we examined the serum levels of G-CSF in patients with infection. Serum samples from 24 patients in the acute stage of infection (14 men and 10 women, age 65 to 101, without hematologic disorders), as well as samples from 32 age-matched normal elderly volunteers were investigated. Sixteen of the initial 24 patients were reexamined after the recovery phase. G-CSF levels were examined by quantitative enzyme immunoassay. The G-CSF level in normal elderly controls, 25.3 +/- 19.7 pg/mL, was not different from that reported in other findings. There was no statistically significant relationship between their G-CSF level and peripheral white blood cell count or neutrophilic granulocyte count. The G-CSF level in the acute stage of infection was 731.8 +/- 895.0 pg/mL, with a range of 30 to 3,199 pg/mL. There was no significant difference in G-CSF levels between patients with respiratory tract infection and those with urinary tract infection. In all 16 cases examined, the serum G-CSF level in the acute stage of infection was significantly higher than that after recovery phase, the latter being the same as the level in normal elderly controls. G-CSF must therefore play a significant role in human infectious states in vivo.
Similar articles
-
[Serum granulocyte-colony stimulating factor (G-CSF) levels in elderly patients with infections].Hokkaido Igaku Zasshi. 1994 Jul;69(4):847-56. Hokkaido Igaku Zasshi. 1994. PMID: 7525437 Japanese.
-
Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions.Biotherapy. 1992;4(2):147-53. doi: 10.1007/BF02171759. Biotherapy. 1992. PMID: 1377927
-
Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.Haematologica. 1994 Jan-Feb;79(1):7-12. Haematologica. 1994. PMID: 15378942
-
Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor.Chest. 2001 Mar;119(3):981-3. doi: 10.1378/chest.119.3.981. Chest. 2001. PMID: 11243992 Review.
-
Use of granulocyte colony-stimulating factor in the treatment of acute infectious diseases.Curr Opin Hematol. 1997 May;4(3):207-12. doi: 10.1097/00062752-199704030-00009. Curr Opin Hematol. 1997. PMID: 9209838 Review.
Cited by
-
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.Blood. 2013 Sep 5;122(10):1707-11. doi: 10.1182/blood-2013-05-500959. Epub 2013 Jul 29. Blood. 2013. PMID: 23896413 Free PMC article. Review.
-
G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism.Blood. 2006 Oct 1;108(7):2438-45. doi: 10.1182/blood-2006-04-013755. Epub 2006 May 30. Blood. 2006. PMID: 16735597 Free PMC article.
-
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis.Nat Rev Rheumatol. 2009 Oct;5(10):554-9. doi: 10.1038/nrrheum.2009.178. Nat Rev Rheumatol. 2009. PMID: 19798030 Review.
-
Innate immune regulation by STAT-mediated transcriptional mechanisms.Immunol Rev. 2014 Sep;261(1):84-101. doi: 10.1111/imr.12198. Immunol Rev. 2014. PMID: 25123278 Free PMC article. Review.
-
On the origin of myeloid-derived suppressor cells.Oncotarget. 2017 Jan 10;8(2):3649-3665. doi: 10.18632/oncotarget.12278. Oncotarget. 2017. PMID: 27690299 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical